Forest to acquire rights to Merck's Saphris

Singapore: US based Forest Laboratories plans to acquire exclusive rights in the United States for Saphris (asenapine) s...

December 5, 2013 | Thursday | News
FDA approves GSK meningococcal vaccine

Singapore: The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's vaccine MenHibrix (meningococcal gr...

June 15, 2012 | Friday | News
Patrys gets 2nd Aus patent for cancer drug

Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted a second Australian patent f...

November 19, 2013 | Tuesday | News
BMS to develop novel therapies for Parkinsons' disease

Singapore: Vanderbilt University, US, and Bristol-Myers Squibb signed a collaboration agreement for the R&D and comm...

September 25, 2012 | Tuesday | News
Glenmark receives two ANDA approvals from the FDA

Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food and Drug Administratio...

March 29, 2016 | Tuesday | News
Researchers working on new drug for Lupus

Singapore: It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year o...

July 20, 2012 | Friday | Analysis
Stem cell therapy effective in liver cirrhosis

Singapore: A study conducted by Beike Biotechnology Company in conjunction with physicians and researchers at two Chines...

July 4, 2012 | Wednesday | News
Old drug gives hope for new treatment in autism

Singapore: Autism results from abnormal cell communication. Testing a new theory, researchers at the University of Calif...

March 15, 2013 | Friday | News
Boehringer, Swiss institute collaborate on diabetes and obesity research

Singapore: Boehringer Ingelheim and the Institute of Molecular Health Science and the Institute of Food, Nutrition and H...

September 7, 2012 | Friday | News
Omega-3 can reduce brain problems after stroke

Singapore: A new study by researchers at Columbia University Medical Center, US, revealed that injection of triglyceride...

February 22, 2013 | Friday | News
KHK advances DsiRNA cancer target, pays $5 mn

Singapore: Dicerna Pharmaceuticals, a RNA interference (RNAi) company focused on developing breakthrough oncology thera...

January 4, 2013 | Friday | News
Celgene halts phase III trial of cancer drug Revlimid

Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open...

July 19, 2013 | Friday | Regulatory
BMS seeks Hep C therapy approval in Japan

Singapore: Bristol-Myers Squibb has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices...

November 7, 2013 | Thursday | News
Daiichi US appoints Glenn Gormley as chairman

Singapore: Daiichi Sankyo has appointed Dr Glenn Gormley, as president and chairman of Daiichi Sankyo, US. Dr Gormley w...

October 4, 2013 | Friday | Influencers
Singapore nod for BMS, Pfizer heart drug

Singapore: Health Sciences Authority (HSA) in Singapore has approved new treatment, apixaban (Eliquis), marketed by phar...

November 25, 2013 | Monday | News
Aus firm to raise $10 mn for multiple sclerosis drug

Singapore: Australia medical biotechnology company, Innate Immunotherapeutics, plans to raise up to $10.93 million (A$12...

November 27, 2013 | Wednesday | News
WuXi PharmaTech partners with Pharmacyclics

Singapore: Shanghai SynTheAll (STA) Pharmaceutical, subsidiary of WuXi PharmaTech, a leading pharmaceutical, biotechnolo...

November 19, 2013 | Tuesday | News
BHR expands brain injury treatment trial

Singapore: BHR Pharma has started recruiting patients, who are suffering from severe traumatic brain injury (TBI), for t...

June 13, 2012 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls